BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12624151)

  • 1. The RNASEL 471delAAAG allele and prostate cancer in Ashkenazi Jewish men.
    Kotar K; Hamel N; Thiffault I; Foulkes WD
    J Med Genet; 2003 Mar; 40(3):e22. PubMed ID: 12624151
    [No Abstract]   [Full Text] [Related]  

  • 2. RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.
    Orr-Urtreger A; Bar-Shira A; Bercovich D; Matarasso N; Rozovsky U; Rosner S; Soloviov S; Rennert G; Kadouri L; Hubert A; Rennert H; Matzkin H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):474-9. PubMed ID: 16537704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNASEL mutations in hereditary prostate cancer.
    Chen H; Griffin AR; Wu YQ; Tomsho LP; Zuhlke KA; Lange EM; Gruber SB; Cooney KA
    J Med Genet; 2003 Mar; 40(3):e21. PubMed ID: 12624150
    [No Abstract]   [Full Text] [Related]  

  • 4. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
    Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
    Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.
    Rennert H; Bercovich D; Hubert A; Abeliovich D; Rozovsky U; Bar-Shira A; Soloviov S; Schreiber L; Matzkin H; Rennert G; Kadouri L; Peretz T; Yaron Y; Orr-Urtreger A
    Am J Hum Genet; 2002 Oct; 71(4):981-4. PubMed ID: 12145743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel.
    Dagan E; Laitman Y; Levanon N; Feuer A; Sidi AA; Baniel J; Korach Y; Ben Baruch G; Friedman E; Gershoni-Baruch R
    Fam Cancer; 2006; 5(4):389-95. PubMed ID: 16944274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
    Carpten J; Nupponen N; Isaacs S; Sood R; Robbins C; Xu J; Faruque M; Moses T; Ewing C; Gillanders E; Hu P; Bujnovszky P; Makalowska I; Baffoe-Bonnie A; Faith D; Smith J; Stephan D; Wiley K; Brownstein M; Gildea D; Kelly B; Jenkins R; Hostetter G; Matikainen M; Schleutker J; Klinger K; Connors T; Xiang Y; Wang Z; De Marzo A; Papadopoulos N; Kallioniemi OP; Burk R; Meyers D; Grönberg H; Meltzer P; Silverman R; Bailey-Wilson J; Walsh P; Isaacs W; Trent J
    Nat Genet; 2002 Feb; 30(2):181-4. PubMed ID: 11799394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
    Casey G; Neville PJ; Plummer SJ; Xiang Y; Krumroy LM; Klein EA; Catalona WJ; Nupponen N; Carpten JD; Trent JM; Silverman RH; Witte JS
    Nat Genet; 2002 Dec; 32(4):581-3. PubMed ID: 12415269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
    Rökman A; Ikonen T; Seppälä EH; Nupponen N; Autio V; Mononen N; Bailey-Wilson J; Trent J; Carpten J; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Am J Hum Genet; 2002 May; 70(5):1299-304. PubMed ID: 11941539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
    Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
    Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
    Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.
    Lehrer S; McCurdy LD; Stock RG; Kornreich R; Stone NN; Eng C
    Cancer Genet Cytogenet; 2000 Oct; 122(2):131-3. PubMed ID: 11106824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
    Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
    Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
    Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
    Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No fumarate hydratase (FH) mutations in hereditary prostate cancer.
    Lehtonen R; Kiuru M; Rökman A; Ikonen T; Cunningham JM; Schaid DJ; Matikainen M; Nupponen NN; Karhu A; Kallioniemi OP; Thibodeau SN; Schleutker J; Aaltonen LA
    J Med Genet; 2003 Mar; 40(3):e19. PubMed ID: 12624148
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland.
    Cybulski C; Wokołorczyk D; Jakubowska A; Gliniewicz B; Sikorski A; Huzarski T; Debniak T; Narod SA; Lubiński J
    Urol Int; 2007; 79(1):44-9. PubMed ID: 17627168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
    Petrukhin L; Dangel J; Vanderveer L; Costalas J; Bellacosa A; Grana G; Daly M; Godwin AK
    Cancer Res; 1997 Dec; 57(24):5480-4. PubMed ID: 9407954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
    Roa BB; Savino CV; Richards CS
    Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the RNASEL gene in familial and sporadic prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Am J Hum Genet; 2002 Jul; 71(1):116-23. PubMed ID: 12022038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for genetic variants associated with cutaneous malignant melanoma in the Ashkenazi Jewish population.
    Loo JC; Paterson AD; Hao A; Shennan M; Peretz H; Sidi Y; Hogg D; Yakobson E
    J Med Genet; 2005 May; 42(5):e30. PubMed ID: 15863662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.